Wang Zhengkun, Liu Xichun, Liu Xiaolei, Niu Dongguang
Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, People's Republic of China.
Department of General Surgery, Affiliated Hospital of Qingdao University, Qingdao City, Shandong Province 266000, People's Republic of China.
Cancer Manag Res. 2020 Jul 30;12:6629-6640. doi: 10.2147/CMAR.S258178. eCollection 2020.
Gastric cancer (GC) is a gastrointestinal tumor. This study is aimed to explore the regulatory mechanism of long non-coding RNA BLACAT1 (BLACAT1)/microRNA-149-5p (miR-149-5p)/KIF2A cascade on GC.
The expression of BLACAT1, miR-149-5p and KIF2A in GC was detected by qRT-PCR. The proliferation, migration and invasion of GC cells in vitro were analyzed by MTT, wound-healing and transwell assay, respectively. The xenograft tumor model was constructed in nude mice to confirm the inhibition effect of BLACAT1 knockdown on GC in vivo. Then, dual-luciferase reporter assay was used to detect the interactions among BLACAT1, miR-149-5p and KIF2A. Western blot assay was performed to determine the protein expression of KIF2A.
The expression of BLACAT1 and KIF2A was up-regulated in GC, but miR-149-5p expression was down-regulated. Silencing of BLACAT1 retarded the proliferation, migration and invasion of GC cells in vitro and the growth of tumor xenograft in vivo. Moreover, BLACAT1 acted as the molecular sponge of miR-149-5p to up-regulate KIF2A expression. At last, feedback experiments suggested that BLACAT1 accelerated the proliferation, migration and invasion of GC cells by regulating miR-149-5p/KIF2A axis.
BLACAT1 facilitated the tumorigenesis of GC through regulating miR-149-5p/KIF2A axis, which indicated BLACAT1/miR-149-5p/KIF2A cascade may be a new therapeutic target.
胃癌(GC)是一种胃肠道肿瘤。本研究旨在探讨长链非编码RNA BLACAT1(BLACAT1)/微小RNA-149-5p(miR-149-5p)/驱动蛋白家族成员2A(KIF2A)级联对胃癌的调控机制。
采用qRT-PCR检测胃癌组织中BLACAT1、miR-149-5p和KIF2A的表达。分别通过MTT法、划痕实验和Transwell实验分析胃癌细胞在体外的增殖、迁移和侵袭能力。构建裸鼠异种移植瘤模型,以证实敲低BLACAT1对体内胃癌的抑制作用。然后,采用双荧光素酶报告基因实验检测BLACAT1、miR-149-5p和KIF2A之间的相互作用。通过蛋白质免疫印迹法检测KIF2A的蛋白表达。
BLACAT1和KIF2A在胃癌组织中的表达上调,但miR-149-5p的表达下调。敲低BLACAT1可抑制胃癌细胞在体外的增殖、迁移和侵袭以及体内肿瘤异种移植瘤的生长。此外,BLACAT1作为miR-149-5p的分子海绵上调KIF2A的表达。最后,反馈实验表明BLACAT1通过调节miR-149-5p/KIF2A轴促进胃癌细胞的增殖、迁移和侵袭。
BLACAT1通过调节miR-149-5p/KIF2A轴促进胃癌的发生发展,提示BLACAT1/miR-149-5p/KIF2A级联可能是一个新的治疗靶点。